Navigation Links
Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round, Engages US Capital Partners as Investment Bank
Date:4/6/2017

Provia Laboratories LLC (Provia) engaged US Capital Partners Inc. (US Capital) as its strategic advisor for a $2M capital raise. Details available at http://www.provialabs.com/investor-relations. Provia will use the new financing primarily to expand its sales and marketing activities and general working capital as the business grows and develops new products and services. US Capital recently completed an in-depth market review and due diligence evaluation of Provia, prepared the offering documents, and has begun raising capital from its large network of investors.

Provia focuses on working with stem cells for autologous use (cells from you, for you). Under the brand Store-A-Tooth, Provia offers a service for families to preserve the valuable mesenchymal stem cells found in their children’s baby teeth and wisdom teeth for their future stem cell therapy needs. Mesenchymal stem cells (MSCs), like those found in teeth, are different than those collected from umbilical cord blood as they can differentiate into cells for repair and regeneration of bone, cartilage, tendon, nerve, and heart tissue – making them relevant to the rapidly growing field of regenerative medicine. MSCs are the most published type of stem cell (BioInformant), more so than controversial embryonic stem cells or even the hematopoietic stem cells found in bone marrow and umbilical cord blood.

In addition to the Store-A-Tooth service, Provia’s state-of-the-art cGMP stem cell laboratory provides the research community with cell and tissue related products and services and has a pipeline of products in development to serve the personalized/autologous cell and tissue therapeutics space.

US Capital is a private investment bank headquartered in San Francisco. Through its affiliate broker dealer, US Capital Global Securities, LLC, the firm facilitates equity private placements, makes direct debt investments, participates in debt facilities, and has a wide distribution for these services and financial products for small and medium-sized businesses.

“As the field of regenerative medicine develops, there are relatively few opportunities for investors to translate the incredible scientific potential of stem cells, regenerative medicine, and specifically autologous treatments into a clear return on investment. Stem cell banking and manufacturing, such as for the regenerative stem cells found in teeth, represent a way to do that,” says Howard Greenman, CEO of Provia Laboratories. He added, “Unlike traditional therapeutic development whereby the discoverer and developer of the therapy yields the largest returns, with autologous stem cell and tissue therapies, the larger economic opportunities may lie in the procurement of the cells, the preservation of the cells, and the manufacturing of the cells into therapeutic products. Provia's role is to procure, bank, and manufacture cells and tissues for current and future autologous therapies – valuable services, solid science, and good business.”

“US Capital is extremely pleased to be assisting Provia with its business financing needs in a strategic investment banking role, as the company moves into the next phase of its business expansion,” said Jeffrey Sweeney, Chairman and CEO at US Capital Partners. “The opportunity to participate in Provia’s $2 million financing raise is now open to eligible investors through our digital investment platform, available at http://www.uscgs.com".

About Provia Laboratories, LLC
Provia is a revenue-generating stem cell processing, manufacturing, and bio-storage company with a leading position in dental stem cell storage and related services. Provia’s primary service, Store-A-Tooth™, provides private storage of stem cells from children’s teeth for future use in the child’s personalized regenerative medicine. Store-A-Tooth™ is a similar service to cord blood stem cell banks like ViaCord (purchased by PerkinElmer) and Cord Blood Registry (purchased by AMAG Pharma). Provia has a proprietary set of protocols for cell processing, expansion, validation, and cryopreservation. Provia’s laboratory provides these services under FDA guidelines for current good manufacturing practice (cGMP) for human cell and tissue products. http://www.provialabs.com or http://www.store-a-tooth.com.

About US Capital Partners Inc.
Since 1998, US Capital Partners has been providing well-structured, custom finance solutions to private and public companies in the United States and abroad. Headquartered in San Francisco, US Capital Partners, operating with its affiliate US Capital Global Securities, LLC, is a full-service private investment bank with a wide distribution for debt and equity private placements. The group makes debt investments between $500,000 and $100 million, participates in debt facilities, and offers asset management, financial advisory services for buy-side and sell-side engagements, and capital formation, including early-stage financings requiring equity or debt. For more information, visit http://www.uscapitalpartners.net.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14225241.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Provia Laboratories™ Prepares for Global Expansion, Closing Institutional Financing Summer, 2016
2. AAIPharma Services Corp. / Cambridge Major Laboratories, Inc. Selects Freeslate Powder Dispensing System To Increase Its Solid State Capabilities
3. OPTIMAL Pain & Regenerative Medicine Specialists Offer Patients New Relief with PRP Therapy and Autologous Stem Cell Therapy
4. Liquid Vitamin Company, drEames Maximum Life Launches New Website
5. South Florida Company, Lice Troopers Has an All-natural Cure for Head Lice as 60 percent of lice are resistant to chemicals
6. Regenerative Agriculture Products & Services Company, Advancing Eco Agriculture, Discuss Initiative to Test Regenerative Practices to Restore Soil Quality
7. Agein Corporation, a Leading Anti-Aging Company, Responds to Research Showing More Men Turning to Cosmetic Surgery to Increase Work Opportunities
8. Affordable Party Dresses Provided by the Distinguished Dress Company, iFitDress.com
9. Weaver Nut Company, Inc. Introduces White Proso Hulled Millet to Their Healthy Choices Product Line
10. Cold Craft, Inc., a Silicon Valley Heating Company, Prepared to Supply Space Heaters for Customers Awaiting Equipment or Repairs
11. Discount Prom Gowns From a Well-Known Company, iFitDress.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
Breaking Medicine Technology: